contact us   |   career   |   sitemap
History of Development
  • Launch of PEARS (Platform for Electronic Adverse Reports Submission), an online safety reporting system.
  • Collaboration with Affiliated Hospital of Guizhou Medical University (“GMUAH”), a strategic collaboration on management of clinical trials in China
  • 3rd International Conference on Phase 1 and Early Phase Clinical Trials (“ICPOEP 2016”)
  • HKU Phase 1 Clinical Trials Centre and 7 additional clinical specialties (including clinical immunology, gastroenterology & hepatology, nephrology, neurology, oncology, orthopaedics & traumatology, and paediatrics & adolescent medicine) received official accreditation by the CFDA on July 20, 2016
  • 2nd International Conference on Phase 1 and Early Phase Clinical Trials (“ICPOEP 2015”)
  • Press conference on “HKU Phase 1 Clinical Trials Centre moves forward to its 1st Anniversary Focus on phase 1 and early phase clinical trials to bring novel treatments”
  • Establishment of the Volunteer Resource Centre (“VRC”)
  • Inauguration of ICN, a 14-membered network of academic and government-based research institutions that collaborate to connect excellence in clinical research
  • Successfully finished the subject recruitment of the first phase 1 healthy volunteer clinical study in HKU Phase 1 Clinical Trials Centre within one month
  • Initiation of the first clinical study in HKU Phase 1 Clinical Trials Centre
  • Registration of PRACTISE® Core by TransCelerate with respect to fulfillment of its minimum criteria for ICH GCP investigator site personnel training
  • Collaboration on TRREE, an online platform on training and resources in research ethics evaluation
  • Formation of an alliance site collaboration with PAREXEL
  • Launch of CREDIT Solutions, a clinical research electronic data management service
  • Launch of TRACE (Trials Recording and Accelerating Central Electronic System), an in-house clinical study tracking system
  • Official launch of PRACTISE®, a professional training programme for investigators and study site personnel
  • Reorganization of the Board of Directors into the Committee of Management
  • CFDA re-inspection
  • Launch of MedDrop, a professional study drug disposal service
  • Establishment of a partner site alliance with Quintiles
  • Establishment of CORE (Centre of Research Excellence) in collaboration with Pfizer
  • Launch of ArchiveEasy, a study site document archiving service
  • Clinical Trials Magnifier Conference in Malaysia
  • Organization of the first Clinical Trial Magnifier Conference in Hong Kong
  • Launch of Clinical Trial Magnifier, a monthly online newsletter on international trends of clinical research
  • Establishment of BPAT (Business & Project Acceleration Team)
  • Launch of clinical research coordinator support service (subsequently branded CRISP, Clinical Research Investigative Site Professionals)
  • Accreditation of seven clinical specialties of HKU/QMH by CFDA
  • Establishment of ECDC (Early Clinical Development Centre) in collaboration with Wyeth
  • Foundation of the HKU Spinal Cord Injury Fund
  • Launch of ClinCluster, a multicentre study site management platform
  • Launch of the Master of Public Health programmes in clinical trials research methodology and medical statistics
  • Launch of ALab, a central laboratory service
  • Biotechnology Forum
  • Organization of the first training workshop for the research ethics committee members in Hong Kong
  • Establishment of the Board of Directors
  • Establishment of HKU/HA HKW IRB, the joint Institutional Review Board of HKU and Hospital Authority Hong Kong West Cluster
  • Accreditation of QMH’s clinical laboratories by CAP (College of American Pathologists)
  • The first study site inspection by Japan MHLW (Ministry of Health, Labour and Welfare) in Hong Kong
  • Publication of the first HKU-CTC Annual Report
  • Successful facilitation of the development of a standard indemnity agreement for sponsored clinical studies acceptable to the industry, the HA (Hospital Authority) and HKU
  • Organization of the first DIA (Drug Information Association) meeting in Hong Kong
  • Launch of the Master of Medical Sciences Programmes in Clinical Trials Research Methodology and Medical Statistics
  • Foundation of HKU-CTC
  • Initiation of the first industry-sponsored clinical study coordinated by HKU-CTC
  • The first US FDA inspection in Hong Kong